LONDON and AMSTERDAM, May 27, 2025 (GLOBE NEWSWIRE) — Hivello, a DePIN aggregator that enables users to earn by monetizing […]
Category: Press Releases
TomoCredit Unveils TomoIQ: AI-Powered Financial Wellness Platform to Build Smarter, Inclusive Financial Future for Everyone
, /PRNewswire/ — TomoCredit, the leading personal financial wellness platform, is proud to announce the launch of TomoIQ, a groundbreaking […]
7Rivers Achieves Snowflake Financial Services Industry Competency
, /PRNewswire/ — 7Rivers, a Premier Snowflake Services Partner and leader in data and AI consulting, announced that it has […]
Scrum Alliance® Wins 2025 Culture of Good Community Impact Award
, /PRNewswire/ — Scrum Alliance is proud to announce that it has been named a winner of the 2025 Culture […]
VetsinTech Accelerates National Footprint with Chapter Expansion During Military Appreciation Month
, /PRNewswire/ — VetsinTech (ViT), the only nonprofit devoted 100% to supporting veterans through tech-based programs and opportunities in education, […]
noBGP Declares Independence from BGP, Revolutionizing Cloud Connectivity
Startup’s networking platform eliminates the internet’s legacy routing protocol to deliver automated, secure cloud networking , /PRNewswire/ — In a bold […]
Vemanti Group Announces Executive Leadership Appointment
Irvine, CA, May 27, 2025 (GLOBE NEWSWIRE) — Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTCPK: VMNT) today announced the […]
Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives
RA’ANANA, Israel, May 27, 2025 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a […]
SEALSQ Invests in Wecan Token to Advance Post-Quantum Digital Identity and Strengthen Blockchain Security, following a Strategic Partnership with SOLANA
Geneva, Switzerland, May 27, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or the “Company”), a leader in Semiconductors, […]
STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer
STC-15 has demonstrated durable clinical activity and tolerability to progress into a combination study with a checkpoint inhibitor Collaboration enables […]